Sign In
Get Clay Free →

Suggestions

    Erica Hall

    Vice President at Evercore

    Erica Hall is a Managing Director at Evercore.1 She has been in this position since February 2024.1 Previously, she was a Vice President at Evercore from March 2020 to February 2024, focusing on Healthcare M&A.1 She initially joined Evercore as an M&A Associate in August 2016.1 Erica earned a B.S. in business administration from Bucknell University, an MBA from University of Pennsylvania’s Wharton School, and an M.A. in international studies from the University of Pennsylvania.2

    Before joining Evercore, Erica Hall worked as a Capital Markets Analyst at Developing World Markets and Cowen and Company. Since joining Evercore in 2016, Erica has advised Bristol-Myers Squibb on its acquisitions of Celgene and Mirati Therapeutics, and Takeda on its acquisitions of Shire and Nimbus Therapeutics’ TYK2 inhibitor.2 Ms. Hall has also completed a variety of financing transactions for Madrigal Pharmaceuticals, Royalty Pharma and Halozyme Therapeutics, among other clients.2

    Highlights

    Jun 13 · evercore.com
    Erica Hall - Evercore
    Jan 10 · evercore.com
    Investment Banking - Evercore
    Mar 8 · eepro.naaee.org
    Erica Hall | eePRO
    Featured Leader – Erica Hall - Food Systems Leadership Network
    Jan 1 · naaee.org
    Erica Hall | North American Association for Environmental Education
    Jan 1 · law.richmond.edu
    Erica Hall - School of Law - University of Richmond

    Related Questions

    What specific projects has Erica Hall led at Evercore?
    How did Erica Hall transition from investment banking to M&A?
    What are some notable deals Erica Hall has worked on at Evercore?
    What is Erica Hall's educational background and how has it influenced her career?
    How does Erica Hall's experience in the biopharma sector impact her role at Evercore?
    Erica Hall
    Erica Hall, photo 1
    Erica Hall, photo 2
    Add to my network

    Location

    New York, New York, United States